Target intelligence / Profile preview

RNA, U2 small nuclear 61, pseudogene (RNU2-61P)

Target
RNU2-61P
Molecular classification
Other (pseudogene, small nuclear RNA pseudogene)
01

Overview

RNA, U2 small nuclear 61, pseudogene (RNU2-61P) is a human pseudogene that corresponds to a non-functional copy of the U2 small nuclear RNA gene. U2 small nuclear RNA is a component of the major spliceosome and plays a prominent role in precursor mRNA splicing, but as a pseudogene, RNU2-61P is not believed to produce a functional RNA and has no known biological or disease role, drug interactions, or biomarker utility[1][4][6].\n\n**Context and supporting details:**\n- RNU2-61P is listed in genomic databases as a pseudogene; there is no evidence suggesting it encodes a functional RNA or protein[1][6].\n- Pseudogenes are generally classified outside canonical targets (receptors, enzymes, transporters, transcription factors, etc.) and are not considered direct therapeutic targets.\n- No information was found indicating involvement in disease, pathway, or clinical biomarker data[4][6].\n- No drugs are described to interact with this gene, nor any associated mechanisms of action, as is typical for pseudogenes.\n- The main function of U2 snRNA (of which RNU2-61P is a pseudogene) relates to mRNA splicing as part of the spliceosome, but the pseudogene itself lacks this function[1][6].\n- There were no reported errors, misspellings, or ambiguities specific to this entry beyond the general irrelevance of pseudogenes as molecular drug targets.

Other names
RNU2-61PRNA, U2 small nuclear 61, pseudogene

Beyond the preview

Go deeper on RNA, U2 small nuclear 61, pseudogene (RNU2-61P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U2 small nuclear 61, pseudogene (RNU2-61P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call